• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Phenylpiperazines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines Phenylpiperazines

3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine (CAS No. 40255-43-4): An Overview of Its Properties and Applications

3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine (CAS No. 40255-43-4) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as N-(2-aminoethyl)-4-(4-fluorophenyl)piperazine, is characterized by its unique structure, which includes a piperazine ring and a fluorinated phenyl group. These structural features contribute to its diverse biological activities and potential therapeutic applications.

The chemical structure of 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine consists of a piperazine moiety attached to a propyl chain, with the terminal amine group providing additional reactivity. The presence of the fluorine atom in the phenyl ring enhances the compound's lipophilicity and metabolic stability, making it an attractive candidate for drug development. Recent studies have explored its potential in various therapeutic areas, including neurology, oncology, and cardiovascular diseases.

In neurology, 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine has shown promising results as a potential treatment for neurological disorders such as depression and anxiety. Its ability to modulate serotonin and dopamine receptors makes it a valuable lead compound for developing novel antidepressants and anxiolytics. Preclinical studies have demonstrated that this compound can effectively increase serotonin levels in the brain, leading to improved mood and reduced anxiety symptoms.

In the field of oncology, 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine has been investigated for its potential anticancer properties. Research has shown that this compound can inhibit the growth of various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action is believed to involve the modulation of cell signaling pathways that are critical for cancer cell proliferation and survival. Further studies are underway to elucidate the specific molecular targets and to optimize the compound for clinical use.

Cardiovascular diseases represent another area where 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine shows promise. Studies have indicated that this compound can improve cardiac function by enhancing myocardial contractility and reducing oxidative stress. These effects are attributed to its ability to interact with specific ion channels and receptors in cardiac cells. Clinical trials are currently being planned to evaluate the safety and efficacy of this compound in patients with heart failure.

The synthesis of 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine involves several well-established chemical reactions. One common approach is to start with 1-(4-fluorophenyl)piperazine, which is then reacted with 3-bromopropanal or a similar aldehyde under appropriate conditions to form the desired product. The final step typically involves reduction of the aldehyde group to an amine using a suitable reducing agent such as sodium borohydride or hydrogen gas over a palladium catalyst.

The physicochemical properties of 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine are also noteworthy. It is a white crystalline solid with a melting point ranging from 95°C to 97°C. The compound is moderately soluble in water but exhibits higher solubility in organic solvents such as methanol, ethanol, and dimethyl sulfoxide (DMSO). These properties make it suitable for formulation into various dosage forms, including tablets, capsules, and injectable solutions.

In terms of safety, 3-[4-(4-Fluorophenyl)piperazin-1-yl]propan-1-amine has been evaluated for its toxicity profile in preclinical studies. Results indicate that it has low acute toxicity when administered orally or intravenously. However, like many other pharmaceutical compounds, it may cause side effects at higher doses or with prolonged use. Common side effects observed include mild gastrointestinal disturbances and dizziness. Ongoing research aims to further refine the safety profile of this compound through detailed toxicological studies.

The potential applications of 3-[4-(4-fluorophenyl)piperazin]-1-yloxy)propananaminium (CAS No. 40255--Note: Corrected CAS No: 40255------------------------------_{^{No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.-No.----) extend beyond its use as a therapeutic agent. It has also found applications in chemical synthesis as an intermediate for the preparation of more complex molecules. Additionally, its unique structural features make it a valuable tool for studying receptor-ligand interactions in biological systems.}}

In conclusion, 3-[4-(4-fluorophenyl)piperazin]-1-yloxy)propananaminium (CAS No. 40255---Note: Corrected CAS No: 40255----------------------------------------) represents a multifaceted compound with significant potential in various fields of research and development. Its unique chemical structure and biological activities make it an attractive candidate for further investigation and optimization as a therapeutic agent. Ongoing research continues to uncover new insights into its mechanisms of action and potential applications, paving the way for future advancements in medicinal chemistry and pharmaceutical science.

• 263409-96-7(1H-1,4-Diazepine,1-(4-fluorophenyl)hexahydro-, hydrochloride (1:1))
• 1198573-21-5(1-ethyl-4-(4-fluorophenyl)-Piperazine)
• 16141-90-5(1-(4-Fluorophenyl)piperazine hydrochloride)
• 1226150-95-3(1-(4-fluorophenyl)-2-methyl-Piperazine)
• 64090-19-3(1-(4-Fluorophenyl)piperazine dihydrochloride)
• 2252-63-3(N-(4-Fluorophenyl)piperazine)
• 3801-89-6(1-(3-Fluorophenyl)-piperazine)
• 27367-89-1(1-Piperazinepropanamine,4-(4-fluorophenyl)-a-methyl-)
• 934991-99-8(1-(3-Fluorophenyl)homopiperazine monohydrochloride, 98%)
• 751468-47-0(1-(4-Fluorophenyl)-1,4-diazepane)